Back
Pulmonary hypertension can turn a routine surgical case into a high-risk anesthetic situation within minutes. For aspiring CRNAs, ICU nurses, SRNAs, and nurse anesthesia residents, understanding the right ventricle’s response to increased pulmonary vascular resistance is an important part of building strong clinical judgment.
In this episode, Dr. Matthew Harmon explains what makes pulmonary hypertension so dangerous during anesthesia, which warning signs deserve immediate attention, and how thoughtful planning can help protect right ventricular function. He also breaks down preoperative assessment, induction, ventilation, hemodynamic support, rescue priorities, and postoperative monitoring.
This discussion is designed to help you connect ICU experience with anesthesia decision-making. The goal is not to memorize a single drug sequence. It is to understand the physiology well enough to recognize risk, anticipate instability, and explain the reasoning behind a safe plan.
Key Takeaways
-
Pulmonary hypertension is a high-risk perioperative condition because an increase in pulmonary vascular resistance can quickly overwhelm a vulnerable right ventricle.
-
Classifying the type of pulmonary hypertension is essential because pulmonary arterial hypertension, left heart disease, lung disease, chronic thromboembolic disease, and multifactorial disease do not respond to treatment in the same way.
-
Preoperative assessment should include functional capacity, current symptoms, pulmonary hypertension medications, recent echocardiographic findings, right ventricular function, and right heart catheterization data when available.
-
Hypoxemia, hypercapnia with acidosis, hypothermia, pain with sympathetic stimulation, and inadequate anesthetic depth can raise pulmonary vascular resistance and should be anticipated.
-
Falling end-tidal carbon dioxide, rising central venous pressure, hypotension, and echocardiographic signs of right ventricular dilation may signal worsening forward flow and acute right ventricular failure.
-
Safe care depends on preparation, team communication, appropriate monitoring, uninterrupted disease-specific therapy when indicated, and a clear rescue plan.
Get the Free CRNA School Data Sheet!
Compare every CRNA program’s requirements, deadlines, and interview details, all in one organized spreadsheet. The CRNA School Data Sheet helps you filter programs by ICU experience requirements, GRE, CCRN, last 60 credit GPA, and more so you can build a smarter school list without the confusion.
It’s updated regularly by the CSPA team, making it the easiest way to research and track CRNA school requirements. Bookmark it, plan your next steps, and finally feel confident that you’re staying on top of every requirement.
Access it free here: https://community.
Join Us for Gassed Up: Fired Up for CRNA School The CSPA 2026 Conference
June 12th – 14th at the University of Louisville, KY
Ticket and Agenda Information: https://events.
Want Guaranteed CRNA School Admission?
Learn how CSPA’s Personalized Money-Back Guarantee sets you up for success:
https://community.
Get access to application and interview preparation resources plus ICU Educational Workshops that have helped thousands of nurses accelerate their CRNA success. Become a member of CRNA School Prep Academy:
https://community.
—
Watch the episode here
Listen to the podcast here
Welcome to the CRNA School Prep Academy Podcast
Welcome to the CRNA School Prep Academy Podcast, where we have helped guide more than 10,000 ICU nurses on their path toward CRNA school. Our mission is to combine education, guidance, and professional growth so you can move confidently toward your goal of becoming a CRNA.
You may still be in nursing school, or you may be a seasoned ICU nurse. This podcast is here for you.
In this solo clinical teaching episode, Dr. Matthew Harmon walks through pulmonary hypertension from an anesthesia perspective. He connects core pathophysiology with preoperative assessment, intraoperative planning, early recognition of right ventricular failure, and postoperative care. This is the kind of topic that helps aspiring CRNAs strengthen both their clinical foundation and their ability to explain how they think through high-risk situations.
Why Pulmonary Hypertension Demands Respect in Anesthesia
Consider a patient scheduled for a routine laparoscopic cholecystectomy. She reports mild shortness of breath, has an estimated pulmonary artery systolic pressure of 55 mmHg on a recent echocardiogram, and otherwise appears stable. After induction, her blood pressure falls. Once the endotracheal tube is placed, the end-tidal carbon dioxide reads 18 mmHg. Within minutes, the team is treating a pulseless electrical activity arrest.
The point of this scenario is not that every patient with pulmonary hypertension will deteriorate. It is that a patient can appear compensated before anesthesia while having very little right ventricular reserve. Induction, positive-pressure ventilation, changes in systemic vascular resistance, hypoxemia, hypercapnia, acidosis, pain, or excessive airway pressure may disturb that balance.
For an ICU nurse preparing for CRNA school, pulmonary hypertension is a strong example of why physiology guides anesthesia care. A normal-looking blood pressure before induction does not tell the entire story. The clinician must consider the pressure against which the right ventricle is ejecting and how the planned anesthetic could change that workload.
What Is Pulmonary Hypertension?
Current guidance defines pulmonary hypertension as a mean pulmonary artery pressure greater than 20 mmHg at rest, confirmed by right heart catheterization. This is lower than the older threshold of 25 mmHg. Pulmonary arterial hypertension has additional hemodynamic criteria, including pulmonary vascular resistance greater than 2 Wood units and a pulmonary artery wedge pressure of 15 mmHg or less.
An echocardiogram can estimate pulmonary pressures and provide valuable information about right ventricular size and function, but right heart catheterization remains the standard for hemodynamic confirmation. The American Heart Association and the 2022 ESC/ERS pulmonary hypertension guidance both emphasize classification, risk assessment, optimization, and coordinated perioperative care.
Precapillary and Postcapillary Pulmonary Hypertension
A useful starting point is to separate precapillary disease from postcapillary disease.
Precapillary pulmonary hypertension involves increased resistance within the pulmonary vascular system before blood reaches the left side of the heart. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are examples.
Postcapillary pulmonary hypertension is commonly associated with elevated left-sided filling pressures. If the left ventricle cannot receive or eject additional blood effectively, indiscriminate pulmonary vasodilation may worsen pulmonary congestion. This is one reason the underlying classification should guide the treatment plan.
The Five Clinical Groups
Pulmonary hypertension is commonly divided into five groups:
-
Group 1: Pulmonary arterial hypertension. This includes idiopathic, heritable, drug- or toxin-associated disease, and disease related to conditions such as connective tissue disorders.
-
Group 2: Pulmonary hypertension associated with left heart disease. This is the most common group and may arise from systolic dysfunction, diastolic dysfunction, or valvular disease.
-
Group 3: Pulmonary hypertension associated with lung disease or hypoxia. Examples include chronic obstructive pulmonary disease, interstitial lung disease, and sleep-disordered breathing.
-
Group 4: Pulmonary hypertension associated with pulmonary artery obstruction. Chronic thromboembolic pulmonary hypertension is the main example.
-
Group 5: Pulmonary hypertension with unclear or multifactorial mechanisms. Conditions may include sarcoidosis, sickle cell disease, and selected systemic or hematologic disorders.
The group provides context for why the pulmonary pressure is elevated. It also helps the multidisciplinary team decide which therapies are appropriate and which may introduce additional risk.
Why the Right Ventricle Can Fail So Quickly
The right ventricle is built to move blood through a low-pressure pulmonary circulation. Its wall is thinner than the left ventricular wall, and it generally handles volume better than a sudden increase in afterload.
In chronic pulmonary hypertension, the right ventricle may hypertrophy and dilate to compensate for persistently elevated pulmonary artery pressure. Compensation can make the patient appear stable, but it does not provide unlimited reserve.
If pulmonary vascular resistance suddenly rises, the right ventricle may be unable to generate enough pressure to maintain forward flow. The ventricle dilates, tricuspid regurgitation can worsen, and the interventricular septum may shift toward the left ventricle. This reduces left ventricular filling, cardiac output falls, and systemic blood pressure drops.
Hypotension then reduces right coronary perfusion. The right ventricle becomes more ischemic and less contractile, causing further dilation and worsening output. This self-perpetuating pattern is the right ventricular failure spiral that the anesthesia team is trying to prevent.
Preoperative Assessment: Know the Patient Before Induction
Good preparation begins before the patient enters the operating room. The assessment should answer several questions.
What Is the Patient’s Functional Capacity?
Ask how far the patient can walk on level ground and how they tolerate stairs. New or worsening dyspnea, syncope, chest discomfort, edema, fatigue, or reduced exercise tolerance may suggest declining right ventricular reserve.
Functional capacity should be interpreted with the rest of the clinical picture. A patient with poor exercise tolerance, elevated natriuretic peptides, significant right ventricular dysfunction, or worsening symptoms may need further optimization, specialist input, or care at a center with the appropriate resources.
What Do the Most Recent Studies Show?
Review the most recent echocardiogram for:
-
Estimated pulmonary artery pressure
-
Right ventricular size and systolic function
-
Right atrial enlargement
-
Tricuspid regurgitation
-
Septal flattening or abnormal septal motion
-
Left ventricular function and valvular disease
If right heart catheterization data are available, review the measured pressures, pulmonary vascular resistance, cardiac output, and filling pressures. These values help clarify the severity and type of pulmonary hypertension.
Which Pulmonary Hypertension Medications Is the Patient Taking?
Medication reconciliation deserves close attention. Disease-specific therapies may include prostacyclin pathway medications, endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, or other specialist-directed treatments.
Chronic pulmonary hypertension therapy is commonly continued through the perioperative period according to the patient’s specialist and anesthesia plan. Continuous prostacyclin infusions should not be stopped abruptly because interruption can cause rebound pulmonary hypertension and rapid deterioration. The team should confirm how each medication will be administered while the patient is fasting, during transport, in the operating room, and after surgery.
The Five Preventable Triggers That Raise Pulmonary Vascular Resistance
Dr. Harmon highlights five factors that every anesthesia clinician should anticipate:
-
Hypoxemia
-
Hypercapnia and the resulting acidosis
-
Hypothermia
-
Pain and sympathetic stimulation
-
Inadequate anesthetic depth
Each factor can increase pulmonary vascular resistance and add strain to the right ventricle. They can also occur together. A difficult airway that leads to hypoxemia and hypercapnia, followed by a sympathetic response to stimulation, may create several stressors at once.
The broader lesson is to plan ahead. Preoxygenation, airway strategy, temperature management, analgesia, anesthetic depth, ventilation, and hemodynamic support should be discussed before instability develops.
Induction and Hemodynamic Planning
Induction is a vulnerable period because many anesthetic agents reduce systemic vascular resistance, myocardial contractility, or both. A significant drop in systemic blood pressure can reduce right ventricular perfusion at the same time the ventricle is working against elevated pulmonary pressure.
Dr. Harmon discusses etomidate as one possible induction agent when preserving hemodynamic stability is a priority. He also cautions against a large routine propofol bolus in a patient with minimal cardiopulmonary reserve. The exact drug, dose, and sequence must be individualized to the patient, procedure, monitoring plan, and available support.
The larger principle is to anticipate the blood pressure response. Vasoactive medications, infusion access, monitoring, and additional help should be ready before induction in a patient with severe disease.
Supporting Systemic Pressure
Norepinephrine and low-dose vasopressin are commonly considered when systemic pressure needs support in pulmonary hypertension. The goal is to maintain systemic perfusion and protect right ventricular coronary blood flow without creating an unnecessary increase in pulmonary vascular resistance.
Phenylephrine is not automatically prohibited, but pure alpha stimulation can be less favorable in severe right ventricular dysfunction. Inotropes such as dobutamine or milrinone may be considered when contractility requires support, although tachycardia or systemic hypotension can limit their use. These decisions should be made by the anesthesia team using the patient’s hemodynamics and institutional protocols.
Selective inhaled pulmonary vasodilators, including inhaled nitric oxide or inhaled epoprostenol, may reduce pulmonary vascular resistance while limiting systemic effects. In a high-risk case, the team should know in advance how to obtain, prepare, and administer these therapies.
Ventilation Goals in Pulmonary Hypertension
Ventilation can either protect or challenge the right ventricle. Hypoxemia is a potent cause of pulmonary vasoconstriction, while hypercapnia and acidosis can further increase pulmonary vascular resistance.
The episode emphasizes:
-
Adequate preoxygenation and a deliberate airway plan
-
Avoidance of hypoxemia, hypercapnia, and acidosis
-
Arterial blood gas assessment when the end-tidal carbon dioxide to arterial carbon dioxide gradient needs clarification
-
Lung-protective tidal volumes based on ideal body weight
-
Enough positive end-expiratory pressure to maintain recruitment without excessive intrathoracic pressure
-
Attention to plateau pressure and overall airway pressure
Positive-pressure ventilation may reduce venous return and increase right ventricular afterload. The settings must balance oxygenation, ventilation, lung recruitment, and hemodynamic tolerance.
Choosing an Anesthetic Technique
There is no single anesthetic technique for every patient with pulmonary hypertension. General anesthesia offers control of oxygenation and ventilation, but induction, intubation, positive-pressure ventilation, and emergence can create hemodynamic stress.
A single-shot spinal can produce an abrupt sympathectomy and a rapid reduction in preload and systemic vascular resistance. In a carefully selected patient, a slowly titrated epidural may provide a more controlled neuraxial block. The team must compare the risks of airway management and ventilation with the risks of sympathectomy, sedation, anticoagulation status, surgical needs, and the severity of right ventricular dysfunction.
Dr. Harmon shares an example of using a slowly titrated epidural with vasopressor support for a patient with severe pulmonary hypertension undergoing major vascular surgery. The case illustrates individualized planning, not a universal technique.
Recognizing Acute Right Ventricular Failure Early
Acute right ventricular failure can progress rapidly. Early findings may include:
-
Rising central venous pressure
-
Falling systemic blood pressure
-
A sudden decrease in end-tidal carbon dioxide
-
Reduced cardiac output
-
Compensatory tachycardia
-
Right ventricular dilation on echocardiography
-
Septal flattening that creates a D-shaped left ventricle
-
Worsening tricuspid regurgitation
A low end-tidal carbon dioxide value after intubation should prompt assessment of ventilation and perfusion. If ventilation is adequate but pulmonary blood flow has fallen, the end-tidal carbon dioxide may drop because less carbon dioxide is being delivered to the lungs.
Transesophageal echocardiography can help identify right ventricular dilation, septal shift, and impaired forward flow when it is available and appropriate. The key is to recognize the pattern before profound shock develops.
Rescue the Right Ventricle in Parallel
When the right ventricle begins to fail, the team may need to address several problems at once:
-
Increase inspired oxygen and correct hypoxemia
-
Correct hypercapnia and acidosis
-
Confirm adequate anesthetic depth and analgesia
-
Treat hypothermia
-
Restore systemic pressure and right ventricular perfusion
-
Assess rhythm, preload, contractility, and pulmonary vascular resistance
-
Bring additional clinicians and resources into the room
-
Use echocardiography when available
-
Consider selective pulmonary vasodilation and inotropic support when indicated
-
Escalate toward mechanical circulatory support in a refractory crisis when the institution has that capability
One important warning from the episode is to avoid treating every episode of hypotension with a large fluid bolus. A failing, dilated right ventricle may already be volume overloaded. Additional fluid can worsen septal shift, reduce left ventricular filling, and further lower cardiac output. Volume decisions should be based on the full hemodynamic picture.
For patients at very high risk, rescue planning may include advance coordination with pulmonary hypertension specialists, cardiac anesthesia, critical care, perfusion, and an extracorporeal membrane oxygenation team. Mechanical support is not a last-minute logistical decision.
Extubation and Postoperative Monitoring
The risk does not end when surgery is complete. Coughing, bucking, pain, hypoxemia, hypercapnia, and agitation during emergence can raise pulmonary vascular resistance.
The goal is a smooth, well-controlled transition with adequate oxygenation and analgesia while avoiding excessive respiratory depression. The postoperative destination should match the patient’s disease severity, surgical stress, intraoperative course, and monitoring needs.
Some patients may recover safely in the post-anesthesia care unit. Higher-risk patients may require a step-down unit or intensive care setting for continued hemodynamic and respiratory observation. Chronic pulmonary hypertension therapy should be resumed or continued according to the established plan.
Practical Takeaway for Aspiring CRNAs
Pulmonary hypertension is a useful clinical topic for CRNA school preparation because it requires you to connect pathophysiology, pharmacology, airway management, ventilation, hemodynamics, and teamwork.
Instead of memorizing a list of drugs, practice asking:
-
What is causing this patient’s pulmonary hypertension?
-
How well is the right ventricle functioning now?
-
What could increase pulmonary vascular resistance during this case?
-
How will induction affect systemic pressure and right ventricular perfusion?
-
What findings would tell me forward flow is falling?
-
Which medications, equipment, monitoring, and specialists should be ready?
-
What is the postoperative monitoring plan?
That reasoning is the heart of advanced practice. For every major decision, return to one question: What will this do to the right ventricle?
Educational note: This article summarizes a clinical teaching episode for professional education. It does not replace patient-specific assessment, institutional protocols, specialist consultation, or clinical judgment.
Related Topics to Explore
What Is A CRNA? How Do You Become A CRNA? Plus CRNA Salary Information and the Top 10 Best CRNA Programs! – Learn what CRNAs do, how to become one, and what salary and program details matter most before applying.
CRNA School Cost: A Comprehensive Guide to Paying for CRNA School — Explore realistic costs and financing options for future CRNAs.
Why Your CRNA School Interview Matters Most – Discover why your interview can make or break your CRNA application and how to stand out when it counts.
CRNA School Competition: How Hard Is It To Get Into CRNA School? – Understand what makes CRNA admissions so competitive and how to rise above other applicants.
How to Find a CRNA to Shadow + Questions to Ask When Shadowing a CRNA — Get the CRNA Shadowing experience you need for CRNA school requirements plus learn what to ask the CRNA during your shadowing experience
Why Choose CSPA Over Other Prep Programs? – Learn how guidance rooted in real CRNA admissions experience helps remove the guesswork and gives you clarity tailored to your unique & specific goals, background, and timeline.
Important Links
Join the Free CSPA Community! Connect with Aspiring CRNAs, Nurse Anesthesia Residents, practicing CRNAs, and CRNA Program Faculty Mentors who are ready to support you. Get real answers and expert guidance in a welcoming space that’s free from misinformation and negativity. You don’t have to do this alone! Join Now: https://www.cspaedu.com/community
Get access to application & interview preparation resources plus ICU Educational Workshops that have helped thousands of nurses accelerate their CRNA success. Become a member of CRNA School Prep Academy: https://community.crnaschoolprepacademy.com/join-cspa
Want Guaranteed CRNA School Admission? Learn More about the CSPA Money Back Guarantee here: https://community.crnaschoolprepacademy.com/6-12-month-intensive
Get CRNA School insights sent straight to your inbox! Sign up for the CSPA email newsletter: https://community.crnaschoolprepacademy.com/email-sign-up
Book a mock interview, resume or personal statement critique, transcript review and more: www.teachrn.com
